Showing results (11-20 of 995) with videos related to
Sort By:
Pageof 100
Cancer Research|April 6, 2007
Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancerMeera Nanjundan, Yasuhisa Nakayama, Kwai Wa Cheng, et al.Breast Cancer Research : BCR|January 6, 2012
'Omic approaches to preventing or managing metastatic breast cancerObi L Griffith, Joe W GrayJournal of Cell Communication and Signaling|June 4, 2021
Chemokine signaling in cancer-stroma communicationsArun J Singh, Joe W GrayCancer Cell|March 16, 2010
The rebirth of a phoenix: ovarian cancers are addicted to ErbB-3Gordon B Mills, Yosef YardenCancer Research|May 7, 2013
AMPK: a contextual oncogene or tumor suppressor?Jiyong Liang, Gordon B MillsThe Journal of Clinical Investigation|May 1, 2024
Enhancing anticancer activity of macrophages through rational drug combinationsGordon B Mills, Marilyne LabrieClinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2017
Surviving Ovarian Cancer: An Affair between Defective DNA Repair and RB1Guang Peng, Gordon B MillsExpert Reviews in Molecular Medicine|October 16, 2007
Targeting the lipids LPA and S1P and their signalling pathways to inhibit tumour progressionMandi Murph, Gordon B MillsMolecular Oncology|March 27, 2012
Omics and therapy - a basis for precision medicineJoseph P Garay, Joe W GrayBiorxiv : the Preprint Server for Biology|April 10, 2026
Tumor-immune trajectory context connects static tissue architecture to clinical outcomesEric M Cramer, Randy Heiland, Heber Lima da Rocha, et al.Pageof 100